CYP19A1 and neoplasm: The tumor’s local estrogen level is an important factor that affects the effect of endocrine therapy in ER-positive breast cancer, as mentioned above, the expression and activation of aromatase in CAFs are significantly increased, resulting in increased estrogen levels, which is one of the major sources of tumor local estrogen to maintain the growth of tumor cells (41).